CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. - Test2 - elhamkhani - TriplyDB

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

http://www.wikidata.org/entity/Q33755370

about

Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update Cancer-associated fibroblasts in digestive tumors Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer Cdc42 in oncogenic transformation, invasion, and tumorigenesis Initial steps of metastasis: cell invasion and endothelial transmigration Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma Inter-kingdom Signaling by the Legionella Quorum Sensing Molecule LAI-1 Modulates Cell Migration through an IQGAP1-Cdc42-ARHGEF9-Dependent Pathway A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin.Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility.For robust big data analyses: a collection of 150 important pro-metastatic genes Epithelial-mesenchymal transitions and hepatocarcinogenesis.CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients.Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition.CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma.The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility.Morphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancer.MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1·PARP1·nucleosome intermediate.Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.SNF2H promotes hepatocellular carcinoma proliferation by activating the Wnt/β-catenin signaling pathway CHD1L: a novel oncogene.Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion.Cellular and molecular mechanisms of hepatocellular carcinoma: an update.Reprogramming cellular events by poly(ADP-ribose)-binding proteins Macro domains as metabolite sensors on chromatin.CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma.Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.

P2860

Q21092852-E3E73405-CC25-4270-B8C4-6F5C7DAB464F Q27003050-E7C11564-A050-45DA-8787-37DC2284B21B Q27022816-CE52FC75-34B5-49C9-AB7D-74AD652F9A7D Q27311589-4853A8E2-F055-4E4D-9C47-DEF4037E03EC Q27342714-F84B3117-D907-4A62-B60D-BEAF45743E89 Q28236231-FB5E55EE-96CA-41F4-A45A-3DD7770E8817 Q28238397-0A9B9B11-BBC2-4106-925E-4461FAF12D5B Q28273449-8DB424EE-7B0D-49CC-9505-39ABF651F42A Q28551293-FAF3F675-66BB-4F5F-97E2-945411C27112 Q28597820-E5C4CCFC-8B07-4C63-8C9D-143F1A7A6C54 Q30499285-DA277D36-3779-4647-9BFE-328DC9557E88 Q30533280-38E57F69-4356-4D07-9FEF-099C1C02F58B Q31155755-6776B716-0D40-4BA5-ADD3-6AC0605E298C Q33755466-03E5C201-487D-40A7-BCA3-40E314EF8D75 Q33757826-08864D7E-260A-4AF3-8829-104D4EA13C19 Q33982416-81F7BC1B-6CBF-46B7-A6A0-208AE95CB3FA Q34083417-739C29F4-488C-48A8-BF20-008399529BC9 Q34405052-ED665F86-A347-4669-AFD3-5DC3D32A902B Q34424030-883CD655-25CB-416A-A183-B63A8BFDA0D7 Q34443999-FF1E843B-96B9-4683-8332-60A3B4070C67 Q34771536-C79127AC-4828-43C0-BEE6-CB5ED6ADF0B8 Q34956599-C0C90B75-BB3A-4729-BDF3-6CA1E9676DCD Q35061390-18D8CC0F-9E3D-4E0D-AE7A-2513CBDBE3D5 Q35176391-8A7E012C-40D0-4269-A36D-0ACD84AFC439 Q35551918-DF6BE8E5-19EC-4788-A57A-94B198592DDA Q35809301-16F8EE9A-FD47-4008-8697-1CCB9DD8D932 Q36481781-41144942-C529-4E44-96DD-A3F59D3E6CF2 Q36544520-32637465-6F01-4627-AE34-6E6CA397E3AC Q37107860-2676489F-B0DE-4A66-88DF-A016731144FD Q37597560-5B23490B-3561-473A-B951-57B0E9A47DBE Q37777019-B090F4D1-BF16-442C-B1DF-2647321CA67A Q37800793-6958FEE1-AC4C-46DB-BB8B-1EBB02DCF6D9 Q37974881-EC40864E-34EE-45EA-A6C4-7ACE983FE9D4 Q38046107-555D978A-AF06-457F-B3CA-B6AAC7C02560 Q38069879-1FFF2A91-69C9-48EF-958F-5C9C838D2C00 Q38086003-AFB6C0C4-D3C3-40C9-AE42-40B908F8F124 Q38711185-B86C8D6C-DCC3-4453-BB88-FF927D0F5959 Q38722084-9BBC6071-4689-4E82-B6D7-F621CCDCA0C4 Q38854438-4A6885E7-D7B5-48C8-8636-F4E2E220C84E Q38971921-4E39AFEB-BC46-4E0B-AF23-2B83F524EBD3

P2860

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

http://www.wikidata.org/entity/Q33755370

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

CHD1L promotes hepatocellular ...... e processes in human patients.

@ast

CHD1L promotes hepatocellular ...... e processes in human patients.

@en

type

label

CHD1L promotes hepatocellular ...... e processes in human patients.

@ast

CHD1L promotes hepatocellular ...... e processes in human patients.

@en

prefLabel

CHD1L promotes hepatocellular ...... e processes in human patients.

@ast

CHD1L promotes hepatocellular ...... e processes in human patients.

@en

P1433

Q33755370-FBCA2F53-5FD7-407A-B83D-DA1212B051A7

P1476

Q33755370-183F7182-0651-4B56-918F-89A2238638FE

P2093

Q33755370-4D6D8E60-364D-4F56-B233-FC89E755A98F

Q33755370-59EF7C52-3F14-4BB2-8A10-E343647A28F0

Q33755370-B2F92F64-2E10-46F3-982B-3750E67E4D0C

Q33755370-B61EC4DB-5736-40F7-A1CB-2772A7AD84A8

Q33755370-CB221585-A86E-44FD-9097-09B3C291ADC1

Q33755370-D38A2453-181B-49F4-93CF-8A4CE4DED81E

Q33755370-E9EDFB71-2526-4833-9591-648C998A6AF4

Q33755370-F359D280-8DE8-42F0-AF43-A3A975442D1F

P2860

Q33755370-0421019D-F022-48F9-A678-CA2F1CBB5AAE

Q33755370-0E4A60D7-32FD-4F31-8441-826496488D88

Q33755370-16879569-2B49-489F-91CF-EB653176B438

Q33755370-2205FC47-E2B4-4ADF-8353-91AF47451507

Q33755370-2341D0A0-70E5-401E-8A98-AEB99E2BB46F

Q33755370-367A9C8E-D6E0-40D4-AFC6-B8F8586B6651

Q33755370-37878E47-A057-4418-AB4B-6EB9F28F2859

Q33755370-3CC235CD-62D9-4B5F-9336-38B82B15EE46

Q33755370-4541CD4D-825C-4ADB-A307-271C1C9D8152

Q33755370-461566A1-A854-4B84-B150-5AC908C796AE

P304

Q33755370-813E4A69-D094-42DF-8977-3E25675F4AEA

P31

Q33755370-E283C6B3-9AB9-45A8-86D2-5927F8A63DBB

P356

Q33755370-5545AC4B-9D4B-4217-99D0-B7FD3A582ABB

P407

Q33755370-21BC1EE2-E31F-41AF-ABFC-0FF28247BEC3

P433

Q33755370-653B4C76-2B0A-4F42-B4EA-521CA85F7CE7

P478

Q33755370-F6C2AB3E-DD82-4BF9-9F2D-FF246DE8CA79

P50

Q33755370-0ED888ED-9A2C-4237-BCBF-B155B50F1DDB

Q33755370-556FB34C-2AF4-46C1-A87F-754B237C22D6

Q33755370-6AE30659-1077-4F0C-8CBF-023DDC8B82A4

Q33755370-BF452284-4BA3-4158-810F-7892EB1919C7

Q33755370-DE831226-4DAB-4677-8071-C451B135BEAF

P577

Q33755370-638D1615-C60D-4206-96A6-F2108375E6A3

P698

Q33755370-C0F594B0-ED5E-45F6-B1E4-28B98F1161C9

P932

Q33755370-7317F2F9-7ABB-4350-A2F6-B7AA344E2D8A

P356

P1433

Journal of Clinical Investigation

P1476

CHD1L promotes hepatocellular ...... se processes in human patients

@en

P2093

Dan Xie

http://www.w3.org/2001/XMLSchema#string

Jian Wang

http://www.w3.org/2001/XMLSchema#string

Jun Huang

http://www.w3.org/2001/XMLSchema#string

Kwan Ho Tang

http://www.w3.org/2001/XMLSchema#string

Liang Hu

http://www.w3.org/2001/XMLSchema#string

Sui-Sui Dong

http://www.w3.org/2001/XMLSchema#string

Tim Hon Man Chan

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the CHD family of proteins

Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer

Epithelial-mesenchymal transitions in tumour progression

Rho GTPases and the actin cytoskeleton

Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression

Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton

SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions?

Proteins regulating Ras and its relatives

Rho GTPases and signaling networks

Identification and characterization of hPEM-2, a guanine nucleotide exchange factor specific for Cdc42

P304

1178-1191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI40665

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20335658

http://www.w3.org/2001/XMLSchema#string

P932

2846051

http://www.w3.org/2001/XMLSchema#string